
Sign up to save your podcasts
Or


Frank Holland and the Investment Committee discuss if today’s jobs report gives the Fed the greenlight to resume raising rates. Plus, a strong first months for the semi stocks. The panel debates what’s ahead for the chips in the second half of the year. Bullish calls out on Ford, GM and Tesla. And, the Chart of the Day is Biogen, as it gets FDA approval for its Alzheimer’s treatment.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.5
344344 ratings
Frank Holland and the Investment Committee discuss if today’s jobs report gives the Fed the greenlight to resume raising rates. Plus, a strong first months for the semi stocks. The panel debates what’s ahead for the chips in the second half of the year. Bullish calls out on Ford, GM and Tesla. And, the Chart of the Day is Biogen, as it gets FDA approval for its Alzheimer’s treatment.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,089 Listeners

3,215 Listeners

1,353 Listeners

239 Listeners

152 Listeners

523 Listeners

322 Listeners

67 Listeners

154 Listeners

32 Listeners

47 Listeners

2,162 Listeners

586 Listeners

5 Listeners

553 Listeners

20 Listeners

1,565 Listeners

211 Listeners

300 Listeners

119 Listeners

340 Listeners

826 Listeners

176 Listeners

35 Listeners

12 Listeners

27 Listeners

9 Listeners

16 Listeners

83 Listeners

1 Listeners